On many fronts, raw market data is gathered and compiled. To make sure that only verified and authenticated sources are taken into consideration, data is constantly vetted. Furthermore, data is extracted from numerous reports within our repository and several well-known commercial databases. Understanding the entire value chain is crucial for a thorough understanding of the market, and we gather information from buyers, distributors, and suppliers of raw materials to make this process easier. Trade journals, technical symposia, and surveys are good sources for technical concerns and trends. Technical information is also obtained with an emphasis on white space and freedom of movement from an intellectual property standpoint. Additionally gathered are industry factors pertaining to pricing patterns, constraints, and drivers.
We use simulation models to produce our market estimates and forecasts. A distinct model is built specifically for every investigation. Data is supplied into the model and simultaneously analyzed for pricing patterns, application development, market dynamics, and technology landscape. These parameters are compared, and time series analysis, regression, and correlation are used to quantify their impact across the predicted period. Market forecasting is carried out using a mix of technical analysis, industry experience, and domain knowledge in addition to economic instruments.
Technological market models are utilized for long-term forecasting, while econometric models are typically employed for short-term forecasting. These are grounded in a combination of corporate principles, regulatory frameworks, economic outlooks, and the state of technology. The best method for estimating markets is a bottom-up strategy that integrates data to provide global estimates and analyses important regional markets as distinct entities.
For our reports, this completes the estimating and forecasting process. In-person and telephone comprehensive primary interviews are performed to confirm our results and the presumptions that led to them. In order to ensure a comprehensive and objective picture of the market, interviewees are sought from top organizations across the value chain, including suppliers, technology providers, buyers, and domain experts. Language difficulties are addressed during these interviews, which take place all over the world with the help of local employees and interpreters. Primary interviews not only aid in the validation of data but also improve the caliber of our reports by offering important insights into the market, the state of company now, and expectations for the future.
Research Methodology:
After secondary research provided a fundamental understanding of the worldwide Patient Engagement Solutions Market scenario, extensive primary research was carried out. A number of primary interviews were carried out with industry experts from the supply and demand sides, including C- and D-level executives, product managers, and marketing and sales managers of major manufacturers, distributors, and channel partners from tier 1 and tier 2 companies offering biomarkers, as well as personnel from academia, research, and CROs. These interviews were conducted across five major regions: North America, Europe, Asia Pacific, and the Rest of the World (Latin America & the Middle East & Africa). Participants from the supply-side and demand-side participated in about 70% and 30% of the primary interviews, respectively. Through the use of questionnaires, emails, online surveys, in-person interviews, and phone interviews, this main data was gathered.
Patient Engagement Solutions Market based on Component:
- Hardware
- Software
- Standalone Software
- Integrated Software
- Services
Patient Engagement Solutions Market based on Delivery Mode:
- PREMISE Mode
- CLOUD-BASED Mode
Patient Engagement Solutions Market based on Application:
- Health management
- Home health management
- Social
- Financial health management
Patient Engagement Solutions Market based on Therapeutic Area:
- Chronic diseases
- Cardiovascular diseases (CVD)
- Diabetes
- Obesity
- Other chronic diseases
- Women’s health
- Fitness
- Other Therapeutic Areas
Patient Engagement Solutions Market based on Functionality:
- Introduction
- E-Prescribing
- Virtual Consultation
- Patient/Client Scheduling
- Document Management
Patient Engagement Solutions Market based on End User:
- Providers
- Payers
- Patients
- Other End users
Patient Engagement Solutions Market based on Geography:
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia Pacific (APAC)
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific (RoAPAC)
- Latin America (LATAM)
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa (MEA)
- UAE
- Turkey
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
The CARES (Coronavirus Aid, Relief, and Economic Security) Act, a USD 2 million emergency stimulus package against the coronavirus, was signed into law by the US President in March 2020. The bill increases coverage for COVID-19-affected individuals’ services and treatment. The CARES Act also gives Medicare more latitude in terms of covering telehealth services, permits physician assistants, nurse practitioners, and certified nurse specialists to be certified by Medicare for home health services, and boosts Medicare payments for durable medical equipment and hospital stays linked to COVID-19. It is anticipated that these policies and actions would boost the need for and use of patient engagement solutions in important global markets.
In the past, payers have made large investments in proprietary systems and infrastructure. These organisations will face financial difficulties in moving or combining these systems with patient engagement solutions. Additionally, their current systems, which are designed to manage only their present needs, will need to be modified. Additionally, the current IT architecture would need to be changed in order to transition to cloud-based patient engagement systems, particularly in hospitals that now act as hubs for a number of doctors, labs, and chemists. Therefore, obtaining the resources necessary to accomplish widespread interoperability and interconnectivity may impede these healthcare organisations’ shift to cloud-based patient engagement programmes.
Software solutions for healthcare IT systems are expensive. These systems may have higher maintenance and software update expenses than software prices. Software updates and support services add up to a recurrent expense that accounts for over 30% of the total cost of ownership. The scarcity of proficient IT specialists within the healthcare sector mandates end-user training to enhance the effectiveness and outcomes of diverse healthcare IT solutions, thus raising the systems’ total cost of ownership. Healthcare IT system evaluations can be difficult since the advantages and organisational impact of these technologies are frequently intangible.
The APAC region’s global market is anticipated to grow due to a number of factors, including the adoption of government initiatives that encourage the adoption of HCIT solutions, rising government spending on healthcare facilities, and the presence of skilled IT experts in emerging Asian countries like China and India. The nation’s healthcare management industry is undergoing significant change, partly due to technological improvements. China is presently dealing with issues like underfunded rural health centres, overworked city hospitals, and a physician shortage across the entire country.
Some of the key players operating in patient engagement solutions market are IBM (US), McKesson Corporation (US), Allscripts (US), Cerner Corporation (US), Epic Systems Corporation (US), Orion Health (New Zealand), GetWellNetwork (US), athenahealth (US), Oneview Healthcare (Ireland), MEDITECH (US), IQVIA (US), Get Real Health (US), Cognizant (US), Symphony Care (US), Harris Healthcare (US), Kareo (US), CureMD Healthcare (US), eClinicalWorks (US), and Lincor Solutions (US), AdvancedMD (US), WellStack(US), IQVIA (US), Vivify Health (US), Medhost (US), Validic (US) MEDISYSINC (US), and Patient point LLC (US).
- This report illustrates the most vital attributes of the Patient Engagement Solutions Market, which are driving and providing opportunities.
- This research gives an in-depth analysis of the Patient Engagement Solutions Market growth on the basis of several segments in the market.
- This report presents the predictions of the past and present trends of the Patient Engagement Solutions Market.
- This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Patient Engagement Solutions Market.
List of Tables
TABLE 1. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 2. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR HARDWARE, BY GEOGRAPHY , 2021-2030 (USD BILLION)
TABLE 3. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR STANDALONE SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR INTEGRATED SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 6. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 7. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 8. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PREMISE MODE, 2021-2030 (USD BILLION)
TABLE 9. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CLOUD-BASED MODE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 10. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 11. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR HEALTH MANAGEMENT, 2021-2030 (USD BILLION)
TABLE 12. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR HOME HEALTH MANAGEMENT, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 13. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR SOCIAL, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 14. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR FINANCIAL HEALTH MANAGEMENT, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 15. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY THERAPEUTIC AREA, 2021-2030 (USD BILLION)
TABLE 16. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CHRONIC DISEASES, 2021-2030 (USD BILLION)
TABLE 17. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CARDIOVASCULAR DISEASES (CVD), BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 18. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR DIABETES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 19. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR OBESITY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 20. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CHRONIC DISEASES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 21. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR WOMEN’S HEALTH, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 22. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR FITNESS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 23. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY FUNCTIONALITY, 2021-2030 (USD BILLION)
TABLE 24. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR INTRODUCTION, 2021-2030 (USD BILLION)
TABLE 25. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR E-PRESCRIBING, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 26. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR VIRTUAL CONSULTATION, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 27. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PATIENT/CLIENT SCHEDULING, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 28. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR DOCUMENT MANAGEMENT, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 29. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 30. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PROVIDERS, 2021-2030 (USD BILLION)
TABLE 31. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PAYERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 32. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PATIENTS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 33. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR OTHER END USERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 34. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 35. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 36. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 37. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 38. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 39. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 40. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 41. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 42. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 43. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 44. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 45. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 46. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 47. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 48. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 49. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 50. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 51. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 52. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 53. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, END USE INDUSTRIES, 2021-2030 (USD BILLION)
TABLE 54. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 55. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 56. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 57. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 58. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 59. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 60. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 61. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 62. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 63. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 64. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 65. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 66. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 67. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 68. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 69. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 70. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 71. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 72. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 73. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 74. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 75. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 76. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 77. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 78. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 79. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 80. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 81. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 82. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 83. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 84. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 85. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 86. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 87. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 88. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 89. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 90. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 91. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 92. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 93. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 94. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 95. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 96. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 97. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 98. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 99. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 100. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 101. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 102. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 103. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 104. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 105. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 106. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 107. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 108. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 109. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 110. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 111. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 112. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 113. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 114. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 115. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 116. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 117. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 118. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 119. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 120. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 121. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 122. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 123. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 124. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 125. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 126. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 127. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 128. ALLSCRIPTS HEALTHCARE, LLC: FINANCIALS
TABLE 129. ALLSCRIPTS HEALTHCARE, LLC: PRODUCTS & SERVICES
TABLE 130. ALLSCRIPTS HEALTHCARE, LLC: RECENT DEVELOPMENTS
TABLE 131. ORION HEALTH: FINANCIALS
TABLE 132. ORION HEALTH: PRODUCTS & SERVICES
TABLE 133. ORION HEALTH: RECENT DEVELOPMENTS
TABLE 134. CERNER CORPORATION: FINANCIALS
TABLE 135. CERNER CORPORATION : PRODUCTS & SERVICES
TABLE 136. CERNER CORPORATION: RECENT DEVELOPMENTS
TABLE 137. MCKESSON CORPORATION: FINANCIALS
TABLE 138. MCKESSON CORPORATION: PRODUCTS & SERVICES
TABLE 139. MCKESSON CORPORATION: RECENT DEVELOPMENTS
TABLE 140. ATHENAHEALTH, INC.: FINANCIALS
TABLE 141. ATHENAHEALTH, INC.: PRODUCTS & SERVICES
TABLE 142. ATHENAHEALTH, INC.: RECENT DEVELOPMENTS
TABLE 143. IBM: FINANCIALS
TABLE 144. IBM: PRODUCTS & SERVICES
TABLE 145. IBM: RECENT DEVELOPMENTS
TABLE 146. MEDECISION: FINANCIALS
TABLE 147. MEDECISION: PRODUCTS & SERVICES
TABLE 148. MEDECISION: DEVELOPMENTS
TABLE 149. GETWELLNETWORK, INC.: FINANCIALS
TABLE 150. GETWELLNETWORK, INC.: PRODUCTS & SERVICES
TABLE 151. GETWELLNETWORK, INC.: RECENT DEVELOPMENTS
TABLE 152. MEDHOST: FINANCIALS
TABLE 153. MEDHOST: RODUCTS & SERVICES
TABLE 154. MEDHOST: RECENT DEVELOPMENTS
TABLE 155. LINCOR: FINANCIALS
TABLE 156. LINCOR: PRODUCTS & SERVICES
TABLE 157. LINCOR: RECENT DEVELOPMENTS
